Bio Rad Laboratories Inc

NYSE:BIOUnited States

Oct 31, 2024

Show headlines and story abstract

• DJ Bio-Rad Laboratories Is Maintained at Buy by Citigroup, from 5:06PM ET on Thursday Oct 31, 2024 by Dow Jones

  5:06PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 17:06 ET (21:06 GMT)
  

• DJ Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital, from 3:49PM ET on Thursday Oct 31, 2024 by Dow Jones

  3:49PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 15:49 ET (19:49 GMT)
  

• DJ Bio-Rad Laboratories Up Over 5%, On Track for Largest Percent Increase Since December 2023 -- Data Talk, from 1:03PM ET on Thursday Oct 31, 2024 by Dow Jones

  1:03PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Bio-Rad Laboratories, Inc. Class A ( BIO ) is currently at $349.24, up $18.67 or 5.65%
  
  --Would be highest close since March 27, 2024, when it closed at $349.56
  
  

• UBS Adjusts Price Target on Bio-Rad Laboratories to $390 From $400, Maintains Buy Rating, from 11:27AM ET on Thursday Oct 31, 2024 by MT Newswires

  11:27AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: BIO
  11:27 AM EDT, 10/31/2024 (MT Newswires) -- Bio-Rad Laboratories (BIO) has an average rating of outperform and price targets ranging from $315 to $469, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic re...

• Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference, from 9:00AM ET on Thursday Oct 31, 2024 by Dow Jones

  9:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
  HERCULES, Calif.--(BUSINESS WIRE)--October 31, 2024--
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the UBS Global Healthcare Conference on Wednesday, November 13, 2024, at 1:15 PM Pacific Time.